Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
A review of the scientific literature was conducted to investigate reducing mortality from acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). This included a review of literature comparing cardiovascular disease (CVD) treatment methods for AMI patients who have T2DM...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb8f588030c447b9920ad02bf807fdf2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bb8f588030c447b9920ad02bf807fdf2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bb8f588030c447b9920ad02bf807fdf22021-11-14T09:00:20ZPerspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials2072-03512072-037810.14341/DM200412-6https://doaj.org/article/bb8f588030c447b9920ad02bf807fdf22016-05-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7563https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378A review of the scientific literature was conducted to investigate reducing mortality from acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). This included a review of literature comparing cardiovascular disease (CVD) treatment methods for AMI patients who have T2DM and those with normal carbohydrate metabolism. These treatments increase the life expectancy and greatly improve the quality of life of patients with acute myocardial infarction in both groups of patients. However, the risk of cardiovascular mortality in patients with T2DM compared with people with normal carbohydrate metabolism remains unchanged. The rapidly growing population of patients with T2DM will soon change our attitude towards the possibility of improving the prognosis and treatment of those with CVD.Sergey V. KakorinRuben A. IskandaryanAshot M. MkrtumyanEndocrinology Research Centrearticletype 2 diabetes mellituschronic heart failurecardiovascular mortalityhyperglycemiaglycated hemoglobininsulin resistancerisk factorsepidemiology of cardiovascular diseaseNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 2, Pp 141-149 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
type 2 diabetes mellitus chronic heart failure cardiovascular mortality hyperglycemia glycated hemoglobin insulin resistance risk factors epidemiology of cardiovascular disease Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
type 2 diabetes mellitus chronic heart failure cardiovascular mortality hyperglycemia glycated hemoglobin insulin resistance risk factors epidemiology of cardiovascular disease Nutritional diseases. Deficiency diseases RC620-627 Sergey V. Kakorin Ruben A. Iskandaryan Ashot M. Mkrtumyan Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
description |
A review of the scientific literature was conducted to investigate reducing mortality from acute myocardial infarction (AMI) in patients with type 2 diabetes mellitus (T2DM). This included a review of literature comparing cardiovascular disease (CVD) treatment methods for AMI patients who have T2DM and those with normal carbohydrate metabolism. These treatments increase the life expectancy and greatly improve the quality of life of patients with acute myocardial infarction in both groups of patients. However, the risk of cardiovascular mortality in patients with T2DM compared with people with normal carbohydrate metabolism remains unchanged. The rapidly growing population of patients with T2DM will soon change our attitude towards the possibility of improving the prognosis and treatment of those with CVD. |
format |
article |
author |
Sergey V. Kakorin Ruben A. Iskandaryan Ashot M. Mkrtumyan |
author_facet |
Sergey V. Kakorin Ruben A. Iskandaryan Ashot M. Mkrtumyan |
author_sort |
Sergey V. Kakorin |
title |
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
title_short |
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
title_full |
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
title_fullStr |
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
title_full_unstemmed |
Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
title_sort |
perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials |
publisher |
Endocrinology Research Centre |
publishDate |
2016 |
url |
https://doaj.org/article/bb8f588030c447b9920ad02bf807fdf2 |
work_keys_str_mv |
AT sergeyvkakorin perspectivesonreducingmortalityattributedtoacutemyocardialinfarctionamongpatientswithtype2diabetesmellitusinmulticenterrandomizedtrials AT rubenaiskandaryan perspectivesonreducingmortalityattributedtoacutemyocardialinfarctionamongpatientswithtype2diabetesmellitusinmulticenterrandomizedtrials AT ashotmmkrtumyan perspectivesonreducingmortalityattributedtoacutemyocardialinfarctionamongpatientswithtype2diabetesmellitusinmulticenterrandomizedtrials |
_version_ |
1718429553500618752 |